$CURX

$4.95 +$0.19 (3.88%) Close

$CURX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 1.6M shares outstanding

Who owns CURX?

By type of holder

Institutions 20.4% Insiders 0.0% Everyone else 79.7%

Concentration Top 10 holders own 20.3%

Geode Capital Management, LLC 2.4% · Citadel Advisors LLC 6.1%

Institutional ownership

20.4%

-0.5 pts vs last qtr

Institutional holders

+2 vs last qtr

Net shares bought

−8.3K

by institutions in Q2 2026

New / sold out

5 / 3

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Renaissance Technologies LLC NEW +52.0K
Virtu Financial LLC NEW +51.2K

Biggest sellers in Q2 2026

Geode Capital Management, LLC −72.8K
Two Sigma Securities, LLC SOLD OUT −56.7K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Curanex Pharmaceuticals Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2025

+92.3%

+92.30% a year

Each share's claim on the business

−48.0%

shrank without buying or selling a share

Diluted shares, split-adjusted

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%

Quarterly turnover

62.3%

of institutional shares changed hands

Top 10 managers, median time held

1 quarter

Super Investors

Investment managers reporting CURX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
GC Geode Capital Management, LLC	38.3K	2.44%	−72.8K (−65.5%)	Q3 '25	0.0%
Shares held by quarter Peak holding111.1K (Q1'26) Change over 8 quarters+38.3K Share of the company2.440% Geode Capital Management, LLC's full portfolio →
CA Citadel Advisors LLC	95.3K	6.07%	+44.7K (+88.4%)	Q3 '25	0.0%
Shares held by quarter Peak holding104.3K (Q4'25) Change over 8 quarters+95.3K Share of the company6.070% Citadel Advisors LLC's full portfolio →

Geode Capital Management, LLC

38.3K

% of company

2.44%

Change vs last qtr

−72.8K (−65.5%)

Held since

Q3 '25

Citadel Advisors LLC

95.3K

% of company

6.07%

Change vs last qtr

+44.7K (+88.4%)

Held since

Q3 '25

11 more super investors behind a free account

See every manager holding Curanex Pharmaceuticals Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting CURX on Form N-PORT; together they hold 7.1% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$30.6K	92.1K	5.87%	0.00%	May 31, 2026
FN Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust	$6.21K	18.7K	1.19%	0.00%	May 31, 2026

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$30.6K

% of company

5.87%

% of the fund

0.00%

As of

May 31, 2026

Fidelity Nasdaq Composite Index Fund

Fidelity Concord Street Trust

Position value

$6.21K

% of company

1.19%

% of the fund

0.00%

As of

May 31, 2026

Comments